Oberoi developed and delivered the “REVITALISE” audit on behalf of Besins Healthcare.
The study attached assesses the work across thirteen UK GP practices. This assessed the care of men with and without type 2 diabetes, who may be at risk of testosterone deficiency and/or erectile dysfunction (ED).
The reason behind the audit was clinical concern that – despite the well-documented relationship between type 2 diabetes, ED and low testosterone – many diabetic men were not being assessed for either condition.
The aim of the project was to identify where the clinical management of these patients could be improved.
Outcomes:
- The prevalence of erectile problems was shown to be considerably higher in men with type 2 diabetes than those without.
- A number of men with type 2 diabetes had not been assessed for ED or testosterone deficiency, missing a valuable opportunity to potentially improve their overall health and quality of life.
- Some men who had been diagnosed with ED or low testosterone, or both, were found to be receiving care that was not in line with current evidence-based guideline recommendations.
Overall, the findings from the REVITALISE audit highlighted the need to improve the clinical management of men with and without type 2 diabetes who are potentially at risk of ED or low testosterone, or both.
Click here to read the full case study, as a PDF, from Diabetes & Primary Care Vol 19 No 2 2017: “REVITALISE audit: Erectile dysfunction and testosterone review in primary care”.